IMS MAXIMS Comments on the Public Accounts Committee Hearing and NAO Report into NPfIT

IMS MAXIMSFollowing the recent UK Parliament Public Accounts Committee hearing and NAO (National Audit Office) Report, commenting Shane Tickell, CEO of UK clinical IT company IMS MAXIMS, said:

"Today's PAC committee hearing and last week's NAO report provide a damning picture of the National Programme from initial concept through to execution. By now the UK should have had among the best nationwide electronic patient record systems in the world. All that was needed was to set national standards and demand high levels of interoperability, then let trusts choose their own solution. This would have given smaller, more innovative suppliers the chance to provide hospitals with systems that worked and which met their real needs.

"Instead we seem to be in a position where - like the banks - the NPfIT contracts are seen as too big to be allowed to fail, and everyone else has to pay the price. This has left the Government trying to salvage a project which should have been abandoned, or completely re-engineered, long ago. The NHS and its patients have been severely let down.

"If the Government really wants an Information Revolution it should revitalise the drive for a nationwide electronic patient record systems and ease the terms and conditions so that bespoke suppliers in healthcare can compete, which ensures that clinicians have access to all relevant patient data in real time. There have been warm words about encouraging greater choice and creating more opportunities to new suppliers, but swift and decisive action is needed. If savings can be made from the remaining NPfIT contracts the money should be reinvested into helping trusts find the IT solutions they need. This relatively small-scale financial stimulus would do much to help patients, hospitals and the healthcare IT sector."

About IMS MAXIMS
IMS MAXIMS specialises in developing clinical and administrative software solutions and currently supports more than 100 organisations and 20,000 users of IMS MAXIMS products.

To find out more about IMS MAXIMS and its products visit www.imsmaxims.com.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...